Fréderic Mazurier

10PUBLICATIONS
21CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 19, 2026
Targeting BMP and TAZ/TEAD mechanotransduction pathways impairs acute myeloid leukemia chemoresistance.

Léa Barral, Nicolas Lespinasse, Camila Martin Cardozo

|Dec 05, 2025
CD9, a tetraspanin in cancer: biology and therapeutic promise in acute leukemia.

Océane Guého, Elie Cousin, Jérémie Rouger-Gaudichon

|May 28, 2022
Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine.

Hassan Dakik, Maya El Dor, Jérôme Bourgeais

|Jun 02, 2021
Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death.

Mélody Caillot, Hassan Dakik, Frédéric Mazurier

|Apr 03, 2021
Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status.

Hassan Dakik, Maya El Dor, Joan Leclerc

|Aug 06, 2020
VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines.

Maya El Dor, Hassan Dakik, Marion Polomski

Pageof 2

Frequent Collaborators

5 joint publications

Fabrice Gouilleux

3 joint publications

Olivier Hérault

3 joint publications

Kazem Zibara

3 joint publications

Hassan Dakik